Sulfonamide compound or salt thereof

Details for Australian Patent Application No. 2009263457 (hide)

Owner Astellas Pharma Inc.

Inventors Kato, Koji; Fukuda, Yuta; Kubota, Hideki; Tsukamoto, Issei; Azami, Hidenori; Kamijo, Kazunori

Agent Davies Collison Cave

Pub. Number AU-A-2009263457

PCT Pub. Number WO2009/157399

Priority 2008-163739 23.06.08 JP

Filing date 22 June 2009

Wipo publication date 30 December 2009

International Classifications

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/443 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/497 (2006.01)

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/36 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/64 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07K 14/705 Peptides having more than 20 amino acids

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/157399 Priority application(s): WO2009/157399

20 January 2011 Amendment Made

  The nature of the amendment is: Amend invention title to read Sulfonamide compounds or salts thereof 2009263526 Daikin industries, ltd. The nature of the amendment is: Amend the invention title to read Power converter

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009263471-Method and apparatus for correcting heliostat

2009263425-User device, base station device, and communication method in mobile communication system